Abstract:Highlights • Intrathecal injection of 10 nmol NPFF potentiated morphine-induced analgesia. • Intrathecal injection of 10 pmol NPFF attenuated morphine-induced analgesia. • Both the pro- and anti-opioid effects of NPFF were mediated by NPFFR2. • Blockade of spinal NPFFR2 selectively regulated MOR agonists-induced analgesia. • NPFF exhibited anti-morphine effects in primary-cultured spinal neurons. Increasing evidence indicates that neuropeptide FF (NPFF) produces analgesic effects and augments opioid-induced analgesia at the spinal level. However, our recent research demonstrated that NPFF exerted complex opioid-modulating effects in an inflammatory pain model after intrathecal (i.t.) injection. Consistent with previous findings, we found that i.t. NPFF dose-dependently attenuated complete Freund's adjuvant-induced pain hypersensitivity. Interestingly, pharmacological results illustrated that NPFF exhibited opposite opioid-modulating effects at the spinal level depending on its administration dosage, wherein i.t. NPFF potentiated morphine-induced anti-allodynia at the dose of 10 nmol, while attenuated morphine analgesia at an ultra-low-dose of 10 pmol. Behavioral results obtained from neuropeptide FF receptor 2 (NPFFR2) knockout animals suggested that both pro- and anti-opioid effects of NPFF were mediated by NPFFR2. Moreover, these modulating effects of spinal NPFFR2 were selectively targeting mu-opioid receptor, had no effect on delta- and kappa-opioid receptor agonist-induced analgesia. Finally, the opioid-modulating effects of NPFF were further verified using in vitro calcium imaging assay, demonstrating that pretreated with NPFF in primary-cultured spinal neurons significantly attenuated the inhibitory effects of morphine on high-K + -induced neuronal excitability. Taken together, our results suggested that NPFF exhibited dual modulating effects on morphine-induced analgesia after i.t. administration, which provides a possible mechanism to explain the complex opioid-modulating effects of endogenous NPFF systems. Graphical abstract Download: Download high-res image (107KB) Download: Download full-size image

Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.

Effects of Neuropeptide Ff System on Cb1 and Cb2 Receptors Mediated Antinociception in Mice

The dual modulating effects of neuropeptide FF on morphine-induced analgesia at the spinal level

Opposite Effects of Neuropeptide FF on Central Antinociception Induced by Endomorphin-1 and Endomorphin-2 in Mice.

Effects of Neuropeptide FF and Related Peptides on the Antinociceptive Activities of VD-hemopressin(α) in Naive and Cannabinoid-Tolerant Mice.

Modulation of neuropeptide FF on endomorphin-2 induced antinociception

Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice.

Neuropeptide Ff Attenuates the Acquisition and the Expression of Conditioned Place Aversion to Endomorphin-2 in Mice

Inhibition of Neuropeptide FF (Npff)-Induced Hypothermia and Anti-Morphine Analgesia by RF9, a New Selective NPFF Receptors Antagonist

Peripheral and Central Sites of Action for Anti-Allodynic Activity Induced by the Bifunctional Opioid/npff Receptors Agonist BN-9 in Inflammatory Pain Model

Systemic Administration of the Bifunctional Opioid/neuropeptide FF Receptors Agonist BN-9 Produced Peripheral Antinociception in Preclinical Mouse Models of Pain

Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice.

Analgesic Activities of the Mixed Opioid and NPFF Receptors Agonist DN-9 in a Mouse Model of Formalin-Induced Orofacial Inflammatory Pain.

Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid/NPFF receptor agonist

BN-9, a Chimeric Peptide with Mixed Opioid and Neuropeptide FF Receptor Agonistic Properties, Produces Nontolerance-Forming Antinociception in Mice.

Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid/NPFF receptor agonist.

Effects of Nociceptin (13–17) in Pain Modulation at Supraspinal Level in Mice

OFP011 Cyclic Peptide as a Multifunctional Agonist for Opioid/Neuropeptide FF Receptors with Improved Blood-Brain Barrier Penetration

Neuropeptide FF Receptor Antagonist, RF9, Attenuates the Fever Induced by Central Injection of LPS in Mice

Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development

Spinal Administration of the Multi-Functional Opioid/neuropeptide FF Agonist BN-9 Produced Potent Antinociception Without Development of Tolerance and Opioid-Induced Hyperalgesia.